[{"address1": "100 Campus Drive", "address2": "Suite 102", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "877 742 8466", "website": "https://www.phathompharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada for an investigational potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. The company was incorporated in 2018 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 452, "companyOfficers": [{"maxAge": 1, "name": "Ms. Terrie J. Curran", "age": 55, "title": "President, CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 1222527, "exercisedValue": 0, "unexercisedValue": 1865398}, {"maxAge": 1, "name": "Mr. David A. Socks", "age": 49, "title": "Co-Founder & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 54167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Azmi  Nabulsi M.D., M.P.H.", "age": 64, "title": "Co-Founder & COO", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 888897, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Molly  Henderson CPA, MBA", "age": 53, "title": "Chief Financial & Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 777763, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aditya  Kohli Ph.D.", "age": 35, "title": "Co-Founder", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 319647, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Cocja", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tom  Harris", "title": "Chief Development Sciences Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eckhard  Leifke M.D., Ph.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin J. Gilligan", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.76, "open": 5.68, "dayLow": 5.36, "dayHigh": 5.7338, "regularMarketPreviousClose": 5.76, "regularMarketOpen": 5.68, "regularMarketDayLow": 5.36, "regularMarketDayHigh": 5.7338, "payoutRatio": 0.0, "beta": 0.538, "forwardPE": -1.38, "volume": 923329, "regularMarketVolume": 923329, "averageVolume": 999601, "averageVolume10days": 935480, "averageDailyVolume10Day": 935480, "bid": 5.49, "ask": 5.57, "bidSize": 2, "askSize": 2, "marketCap": 377443232, "fiftyTwoWeekLow": 5.21, "fiftyTwoWeekHigh": 19.71, "priceToSalesTrailing12Months": 14.367843, "fiftyDayAverage": 6.708, "twoHundredDayAverage": 11.430125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 561757056, "profitMargins": 0.0, "floatShares": 55668060, "sharesOutstanding": 68377400, "sharesShort": 14861562, "sharesShortPriorMonth": 14203975, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.2173, "heldPercentInsiders": 0.0431, "heldPercentInstitutions": 0.99447, "shortRatio": 14.21, "shortPercentOfFloat": 0.3067, "impliedSharesOutstanding": 68377400, "bookValue": -2.739, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -339444992, "trailingEps": -5.74, "forwardEps": -4.0, "enterpriseToRevenue": 21.384, "enterpriseToEbitda": -1.956, "52WeekChange": -0.44023323, "SandP52WeekChange": 0.16050637, "quoteType": "EQUITY", "currentPrice": 5.52, "targetHighPrice": 28.0, "targetLowPrice": 17.0, "targetMeanPrice": 24.625, "targetMedianPrice": 27.5, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 334678016, "totalCashPerShare": 4.895, "ebitda": -287137984, "totalDebt": 518992000, "quickRatio": 5.449, "currentRatio": 5.726, "totalRevenue": 26270000, "revenuePerShare": 0.44, "returnOnAssets": -0.57674, "grossProfits": 21945000, "freeCashflow": -179773248, "operatingCashflow": -247111008, "grossMargins": 0.83536005, "ebitdaMargins": 0.0, "operatingMargins": -4.3295, "financialCurrency": "USD", "symbol": "PHAT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "shortName": "Phathom Pharmaceuticals, Inc.", "longName": "Phathom Pharmaceuticals, Inc.", "regularMarketChangePercent": -4.166671, "regularMarketPrice": 5.52, "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketPrice": 5.61, "postMarketChange": 0.0900002, "regularMarketChange": -0.24000025, "regularMarketDayRange": "5.36 - 5.7338", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 999601, "fiftyTwoWeekLowChange": 0.30999994, "fiftyTwoWeekLowChangePercent": 0.059500948, "fiftyTwoWeekRange": "5.21 - 19.71", "fiftyTwoWeekHighChange": -14.189999, "fiftyTwoWeekHighChangePercent": -0.71993905, "fiftyTwoWeekChangePercent": -44.023323, "earningsTimestamp": 1741267800, "earningsTimestampStart": 1741267800, "earningsTimestampEnd": 1741267800, "earningsCallTimestampStart": 1741267800, "earningsCallTimestampEnd": 1741267800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -5.74, "epsForward": -4.0, "epsCurrentYear": -4.7025, "priceEpsCurrentYear": -1.1738437, "fiftyDayAverageChange": -1.1880002, "fiftyDayAverageChangePercent": -0.177102, "twoHundredDayAverageChange": -5.9101253, "twoHundredDayAverageChangePercent": -0.51706564, "priceToBook": -2.015334, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "postMarketChangePercent": 1.63044, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1572010200000, "cryptoTradeable": false, "marketState": "CLOSED", "postMarketTime": 1740788560, "regularMarketTime": 1740776401, "exchange": "NMS", "messageBoardId": "finmb_613615658", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "displayName": "Phathom Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]